Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 72.34B | 72.60B | 69.54B | 59.34B | 56.54B |
Gross Profit | 17.21B | 16.59B | 15.93B | 14.48B | 14.36B |
EBITDA | 6.94B | 7.33B | 6.73B | 5.70B | 5.83B |
Net Income | 3.55B | 4.24B | 3.96B | 3.71B | 3.54B |
Balance Sheet | |||||
Total Assets | 62.95B | 64.24B | 60.94B | 55.87B | 52.38B |
Cash, Cash Equivalents and Short-Term Investments | 1.20B | 1.56B | 1.10B | 1.73B | 1.32B |
Total Debt | 420.00M | 400.00M | 500.00M | 503.00M | 503.00M |
Total Liabilities | 13.52B | 14.57B | 15.39B | 14.12B | 12.73B |
Stockholders Equity | 49.35B | 49.62B | 45.50B | 41.70B | 39.61B |
Cash Flow | |||||
Free Cash Flow | 2.39B | 3.21B | -377.00M | 508.00M | 2.63B |
Operating Cash Flow | 5.05B | 6.50B | 2.24B | 2.17B | 3.67B |
Investing Cash Flow | -2.19B | -2.98B | -2.82B | -1.56B | -207.00M |
Financing Cash Flow | -2.28B | -1.69B | -1.49B | -1.44B | -1.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥57.86B | 13.05 | 2.73% | 4.63% | 27.74% | ||
70 Neutral | ¥82.14B | 20.19 | 3.40% | 3.99% | -32.61% | ||
69 Neutral | ¥65.93B | 18.57 | 3.83% | -0.35% | -16.23% | ||
69 Neutral | ¥96.28B | 8.23 | 3.37% | -3.45% | -3.91% | ||
66 Neutral | ¥55.39B | 25.39 | 1.09% | 13.62% | 24.54% | ||
65 Neutral | £10.65B | 8.75 | 3.35% | 284.67% | -1.40% | 17.93% | |
63 Neutral | ¥61.48B | 15.56 | 2.29% | 1.11% | ― |